You are here: Home > Therapeutics (former) > Cannabis and Eicosanoids: A Review of Molecular Pharmacology

J Cannabis Ther 2001(1):071-83

Eicosanoids

Cannabis and Eicosanoids: A Review of Molecular Pharmacology

Author
J.M. McPartland

Abstract
Many constituents of cannabis exhibit beneficial anti-inflammatory properties, such as delta-9-tetrahydrocannabinol (THC) in marijuana and gamma-linolenic acid (GLA) in hemp seed oil. The effects of these cannabis constituents on eicosanoid metabolism is reviewed. THC and GLA modulate the arachidonic acid cascade, inhibiting the production of series 2 prostaglandins and series 4 leukotrienes. Cannabinoid receptor- as well as non-receptor-mediated signal transduction pathways appear to be involved. It is proposed that THC acts as a selective cyclooxygenase-2 (COX-2) inhibitor.

Keywords
Cannabis, cannabinoids, tetrahydrocannabinol, marijuana, anandamide, prostaglandins, thromboxanes, leukotrienes, phospholipase, cyclooxygenase, lipooxygenase

PDF of the full text ]

Online Events 2020

Please find all information of IACM Online Events including free videos of the webinars here.

Conference 2022

The 12th IACM Conference on Cannabinoids in Medicine will be we be held on 20 and 21 October 2022 together with the Swiss SSCM in Basel/Switzerland.

Members only

Regular members can sign up for the new member area of the IACM to access exclusive content.

You need to become a regular member of the IACM to access the new member area.

IACM on Twitter

Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.